MedTrace Logo

Clinical Trial Study About Human Adipose-Derived Stem Cells in the Stroke

NCT02813512 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2018-12-07

No results posted yet for this study

Summary

The objective of the study is to confirm the safety and possible efficacy of Adipose-Tissue Derived Stem Cells treatment of chronic stroke. Specifically, the study will transplant autologous ADSCs into brain surrounding ischemic infarct in adult (65-80 years old) subjects who have chronic non-hemorrhagic stroke (\>6 months).

Conditions

Interventions

DRUG

ADSCs

Autologous ADSCs

Sponsors & Collaborators

  • Gwo Xi Stem Cell Applied Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Hualien T Hospital · Hualien Tzu Chi General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-19
Primary Completion
2018-11-27
Completion
2018-11-27

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813512 on ClinicalTrials.gov